Press Releases
11/30/11 Acucela to Present ACU-4429 Phase 1 Data at the 10th International Symposium on
Ocular Pharmacology and Therapeutics
11/29/11 Acucela Inc. Chairman, President and CEO, Ryo Kubota, M.D., Ph.D.,
Named to the Nikkei Business 100
10/12/11 Acucela Announces that Renowned Thought Leader and Ophthalmologist,
Philip J. Rosenfeld, M.D., Ph.D., has joined the Company’s Clinical Advisory Board for ACU-4429
09/13/11 Acucela and Otsuka Pharmaceutical Announce the Initiation of a Phase 1/2 Clinical Trial
for
OPA-6566 in Patients with Open-angle Glaucoma or Ocular Hypertension
08/08/11 Acucela Appoints Michelle Carpenter, J.D., RAC, as Senior Vice President,
Regulatory Affairs & Development Operations
08/02/11 Acucela Inc. Announces Ryo Kubota, M.D., Ph.D., Named to PharmaVOICE 100
04/26/11 Acucela Appoints Seasoned Financial Executive, David L. Lowrance, CPA,
as Chief Financial Officer
04/25/11 Acucela Announces Publication in Retina Showcasing First-Time Demonstration of Dose-Dependent
Visual Cycle Modulation with an Oral, Non-Retinoid Therapy
03/01/11 Acucela Appoints Former DuPont-Merck Pharmaceuticals, Inc. Scientist and Ophthalmic Expert,
Ghanshyam Patil, Ph.D., as Vice President, Research & Development
02/24/11 Acucela to Present at the Life Science Innovation Northwest 2011 Conference
01/18/11 Acucela Appoints Former Novartis Executive and Ophthalmic Expert, Al Reaves, Ph.D., to
Management Team